Skip to Content

b 859 (Flecainide 50 mg)

Pill with imprint b 859 is White, Round and has been identified as Flecainide acetate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; ventricular tachycardia; wolff-parkinson-white syndrome (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 859

Flecainide acetate

Imprint:
b 859
Strength:
50 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide